Cargando…

Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype

Prion diseases or prionoses are a group of rapidly progressing and invariably fatal neurodegenerative diseases. The pathogenesis of prionoses is associated with self-replication and connectomal spread of PrP(Sc), a disease specific conformer of the prion protein. Microglia undergo activation early i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pankiewicz, Joanna E., Lizińczyk, Anita M., Franco, Leor A., Diaz, Jenny R., Martá-Ariza, Mitchell, Sadowski, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474943/
https://www.ncbi.nlm.nih.gov/pubmed/34565486
http://dx.doi.org/10.1186/s40478-021-01261-z
_version_ 1784575335747026944
author Pankiewicz, Joanna E.
Lizińczyk, Anita M.
Franco, Leor A.
Diaz, Jenny R.
Martá-Ariza, Mitchell
Sadowski, Martin J.
author_facet Pankiewicz, Joanna E.
Lizińczyk, Anita M.
Franco, Leor A.
Diaz, Jenny R.
Martá-Ariza, Mitchell
Sadowski, Martin J.
author_sort Pankiewicz, Joanna E.
collection PubMed
description Prion diseases or prionoses are a group of rapidly progressing and invariably fatal neurodegenerative diseases. The pathogenesis of prionoses is associated with self-replication and connectomal spread of PrP(Sc), a disease specific conformer of the prion protein. Microglia undergo activation early in the course of prion pathogenesis and exert opposing roles in PrP(Sc) mediated neurodegeneration. While clearance of PrP(Sc) and apoptotic neurons have disease-limiting effect, microglia-driven neuroinflammation bears deleterious consequences to neuronal networks. Apolipoprotein (apo) E is a lipid transporting protein with pleiotropic functions, which include controlling of the phagocytic and inflammatory characteristics of activated microglia in neurodegenerative diseases. Despite the significance of microglia in prion pathogenesis, the role of apoE in prionoses has not been established. We showed here that infection of wild type mice with 22L mouse adapted scrapie strain is associated with significant increase in the total brain apoE protein and mRNA levels and also with a conspicuous cell-type shift in the apoE expression. There is reduced expression of apoE in activated astrocytes and marked upregulation of apoE expression by activated microglia. We also showed apoE ablation exaggerates PrP(Sc) mediated neurodegeneration. Apoe(−/−) mice have shorter disease incubation period, increased load of spongiform lesion, pronounced neuronal loss, and exaggerated astro and microgliosis. Astrocytes of Apoe(−/−) mice display salient upregulation of transcriptomic markers defining A1 neurotoxic astrocytes while microglia show upregulation of transcriptomic markers characteristic for microglial neurodegenerative phenotype. There is impaired clearance of PrP(Sc) and dying neurons by microglia in Apoe(−/−) mice along with increased level of proinflammatory cytokines. Our work indicates that apoE absence renders clearance of PrP(Sc) and dying neurons by microglia inefficient, while the excess of neuronal debris promotes microglial neurodegenerative phenotype aggravating the vicious cycle of neuronal death and neuroinflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01261-z.
format Online
Article
Text
id pubmed-8474943
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84749432021-09-28 Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype Pankiewicz, Joanna E. Lizińczyk, Anita M. Franco, Leor A. Diaz, Jenny R. Martá-Ariza, Mitchell Sadowski, Martin J. Acta Neuropathol Commun Research Prion diseases or prionoses are a group of rapidly progressing and invariably fatal neurodegenerative diseases. The pathogenesis of prionoses is associated with self-replication and connectomal spread of PrP(Sc), a disease specific conformer of the prion protein. Microglia undergo activation early in the course of prion pathogenesis and exert opposing roles in PrP(Sc) mediated neurodegeneration. While clearance of PrP(Sc) and apoptotic neurons have disease-limiting effect, microglia-driven neuroinflammation bears deleterious consequences to neuronal networks. Apolipoprotein (apo) E is a lipid transporting protein with pleiotropic functions, which include controlling of the phagocytic and inflammatory characteristics of activated microglia in neurodegenerative diseases. Despite the significance of microglia in prion pathogenesis, the role of apoE in prionoses has not been established. We showed here that infection of wild type mice with 22L mouse adapted scrapie strain is associated with significant increase in the total brain apoE protein and mRNA levels and also with a conspicuous cell-type shift in the apoE expression. There is reduced expression of apoE in activated astrocytes and marked upregulation of apoE expression by activated microglia. We also showed apoE ablation exaggerates PrP(Sc) mediated neurodegeneration. Apoe(−/−) mice have shorter disease incubation period, increased load of spongiform lesion, pronounced neuronal loss, and exaggerated astro and microgliosis. Astrocytes of Apoe(−/−) mice display salient upregulation of transcriptomic markers defining A1 neurotoxic astrocytes while microglia show upregulation of transcriptomic markers characteristic for microglial neurodegenerative phenotype. There is impaired clearance of PrP(Sc) and dying neurons by microglia in Apoe(−/−) mice along with increased level of proinflammatory cytokines. Our work indicates that apoE absence renders clearance of PrP(Sc) and dying neurons by microglia inefficient, while the excess of neuronal debris promotes microglial neurodegenerative phenotype aggravating the vicious cycle of neuronal death and neuroinflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01261-z. BioMed Central 2021-09-26 /pmc/articles/PMC8474943/ /pubmed/34565486 http://dx.doi.org/10.1186/s40478-021-01261-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pankiewicz, Joanna E.
Lizińczyk, Anita M.
Franco, Leor A.
Diaz, Jenny R.
Martá-Ariza, Mitchell
Sadowski, Martin J.
Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
title Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
title_full Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
title_fullStr Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
title_full_unstemmed Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
title_short Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
title_sort absence of apolipoprotein e is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474943/
https://www.ncbi.nlm.nih.gov/pubmed/34565486
http://dx.doi.org/10.1186/s40478-021-01261-z
work_keys_str_mv AT pankiewiczjoannae absenceofapolipoproteineisassociatedwithexacerbationofprionpathologyandpromotesmicroglialneurodegenerativephenotype
AT lizinczykanitam absenceofapolipoproteineisassociatedwithexacerbationofprionpathologyandpromotesmicroglialneurodegenerativephenotype
AT francoleora absenceofapolipoproteineisassociatedwithexacerbationofprionpathologyandpromotesmicroglialneurodegenerativephenotype
AT diazjennyr absenceofapolipoproteineisassociatedwithexacerbationofprionpathologyandpromotesmicroglialneurodegenerativephenotype
AT martaarizamitchell absenceofapolipoproteineisassociatedwithexacerbationofprionpathologyandpromotesmicroglialneurodegenerativephenotype
AT sadowskimartinj absenceofapolipoproteineisassociatedwithexacerbationofprionpathologyandpromotesmicroglialneurodegenerativephenotype